2017 ARVO Trustee Candidates

Meet the 2017 BI, CL and VN Trustee candidates. They were each selected in the 2016 elections to run as candidates to run in the 2017 election.

 Biochemestry and Molecular Biology (BI) Section 

  • Cheryl M. Craft, PhD, FARVO
  • T. Michael Redmond, PhD, FARVO

 
 Clinical/Epidemiologic Research (CL) Section 

  • Maureen Maguire, PhD, FARVO
  • Cynthia Owsley, PhD, MSPH, FARVO


 Visual Neuroscience (VN) Section

  • Maureen McCall, PhD

Biochemistry and Molecular Biology (BI) Section 

Cheryl Craft

Cheryl M. Craft, PhD, FARVO, received a BS with honors from Valdosta State University, Georgia and a teaching certificate at Eastern Kentucky University. In 1984, she earned her doctorate in human anatomy and neuroscience from the Biomedical Graduate School, University of Texas Health Science Center at San Antonio. She was awarded a NSRA postdoctoral fellowship to study molecular neurobiology and neurogenetics at the National Eye Institute at the National Institutes of Health.

At the Keck School of Medicine of the University of Southern California (USC), Craft is a tenured Professor in Ophthalmology and Cell and Neurobiology (inaugural Chairman, 1994-2004), was founding Co-Director of the USC Neurological Institute, and was an integral team leader in the creation of the Zilkha Neurogenetic Institute. She is founding Director of the USC Postdoctoral Scholars Program.

In 2015, she was elected as Vice Chair of the Board of Governors for the Association fro Research in Vision and Ophthalmology Foundation. She also serves on the executive and scientific boards for the John Douglas French Alzheimer's Foundation, the California Science Center MUSES Foundation, and President of LA Founder Chapter, Achievement Rewards for College Scientists Foundation, Inc. Her previous academic faculty appointments were in the Department of Psychiatry, University of Texas Southwestern Medical School, Dallas where she was the founding Director of Molecular Neurogenetics for the Schizophrenia Research Center and the Affective Disorders Center. In 1994, she was honored as the inaugural recipient for the Mary D. Allen Endowed Chair in Vision Research at the Doheny Eye Institute. Until 2013, she was a Senior Scientist at the Doheny Eye Institute and served as the Executive Scientific Director of the Mary D. Allen Laboratory for Vision Research. 

 As a neuroscientist, her research focus is on understanding the genes expressed in the eye and pineal gland that interact with the environment for normal high acuity vision to occur. When these genes are abnormal, the defects may lead to loss of sight through photoreceptor cell death and the uncoupling of the body's "biological clock." Her vision research program includes genetically engineered animal models to explore the delicate balance of photoreceptors in maintaining health and preventing disease, especially age-related macular degeneration and Retinitis Pigmentosa.

One of her major goals includes preparing students to become research scientists, physicians and informed citizens. To achieve this goal, she mentors students, postdoctoral fellows, and faculty. For her scientific expertise and achievements, she has received academic awards, major research funding from both government and private foundations, serves on national committees, study sections, and scientific advisory boards.

The California Science Center MUSES honored Dr. Craft as their 43rd Woman of the Year and Keck School of Medicine USC honored her in 2015 for her lifelong commitment to mentoring. 

Commercial and/or financial interests: None.  

T. Michael Redmond small T. Michael Redmond , PhD, FARVO, is a Senior Investigator in, and Chief of the Laboratory of Retinal Cell & Molecular Biology (LRCMB), National Eye Institute (NEI),National Institutes of Health, Bethesda, MD, where he is also Head of the Molecular Mechanisms Section. He received his PhD in 1983 from University College, Dublin (National University of Ireland (NUI)), incorporating graduate training at the Medical University of South Carolina, Charleston, SC, a placement that was made possible by award of the NUI Traveling Studentship Prize in Zoology (1979). 

For his postdoctoral training, he was a Fogarty Visiting Fellow, and then Staff Fellow/Senior Staff Fellow in the LRCMB, NEI (1983-1990), in studies investigating the biochemistry, molecular biology and role in ocular immunology of interphotoreceptor retinoid-binding protein (IRBP). Redmond received tenure as a Research Biologist in the NEI in 1990,becoming a Section Head in the early 2000s. In 2009, he was appointed Chief of the Laboratory of Retinal Cell & Molecular Biology.Redmond has been a member of ARVO and the BI section since 1984, contributing each year to its scientific program. He was named an ARVO fellow (silver) in the inaugural class of 2009. 

Redmond has made important contributions to the mission of ARVO and its Annual Meeting, serving (2011-2014) on the ARVO Annual Meeting Program Committee for the BI Section. In addition to the ARVO Annual Meeting, he is an active participant in other national and international meetings and conferences relating to vision research and retinoid/carotenoid biochemistry.

Redmond has published over 100 peer-reviewed papers, plus many bookchapters and reviews, on his group’s research in retina and retinal pigmentepithelium (RPE) visual cycle biochemistry and molecular biology. Dr. Redmond’s group currently studies the complex catalytic mechanisms of RPE65, mouse models for Leber congenital amaurosis, other aspects of visual cycle biochemistry,systemic carotenoid/retinoid metabolism, and signaling pathways in the RPE andretina.

At the NEI, in addition to his research, he serves as member/chair of committees covering promotion and tenure, and genetic engineering and other core facilities. He is also supervisor of the NEI Genetic Engineering Core facility. Dr. Redmond was an invited participant in the NEI Audacious Goals Initiative Development Meeting in February 2013. He is a member of the Editorial Board of Molecular Vision and has reviewed manuscripts for more than 30 of the top-ranking journals in the fields of vision research, biochemistry, molecular biology and genetics,etc. He also serves as grant reviewer on NIH and several national and international foundation and agency review panels.

 Back to Top

Clinical/Epidemiologic Research (CL) Section

 Maureen Maguire Maureen G. Maguire, PhD, FARVO, is Professor of Ophthalmology and of Biostatistics at the University of Pennsylvania. She received her doctoral degree in Biostatistics from the Johns Hopkins Bloomberg School of Public Health and joined the faculty in the Department of Ophthalmology at the Wilmer Institute, Johns Hopkins University in 1983. In 1994, founded the Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology University of Pennsylvania. Dr. Maguire has been involved in the design and conduct of collaborative clinical research on the prevention and treatment of ocular disease throughout her career. 
She has served in a leadership role for a series of multicenter clinical trials for age-related macular degeneration (AMD), including the Macular Photocoagulation Study (MPS), the Complications of AMD Prevention Trial (CAPT), and the Comparison of AMD Treatments Trials (CATT). She has also led the coordinating center or had a senior position for multicenter clinical research in corneal and ocular surface disease (Collaborative Corneal Transplantation Studies (CCTS), Bacterial Keratitis Study, and the Dry Eye Assessment and Management (DREAM) Study), glaucoma (Glaucoma Laster Trial), and pediatric ocular conditions (Vision In Preschoolers (VIP), Hyperopia in Preschoolers (VIP-HIP), and Telemedicine Approaches to Evaluating\ Acute-Phase Retinopathy of Prematurity (e-ROP) Study), and diabetic retinopathy (Retinopathy in the Chronic Renal Insufficiency Cohort (RCRIC) Study).

Maguire has been an active member of ARVO for more than 30 years having presented in or moderated sessions in most years. She has served on the CL Program Planning Committee (1995-1997, Member; 1997-1998, Chair); the Professional Development & Education Committee (2005-2006, Member; 2006- 2009, Chair); and the Advocacy Pillar Committee (2013). In 2000, she initiated a one-day course in Clinical Trials at the ARVO annual meeting, a course that was later replicated in many venues. She is currently participating in the ARVO Global Mentoring program.

Maguire has more than 200 papers in peer-reviewed literature. Maguire has been the Director of Penn’s Vision Clinician Scientist Program (NEI-K12) since 2004 and mentored clinician scientists, residents, and medical students. She has participated in several NIH and foundation review panels for grant applications. Dr. Maguire has served as an Editorial Board member for Ophthalmology, Cornea, Retina, and Eye & Contact Lens and as a reviewer for 20 biomedical journals. She has chaired or been a member of the Data and Safety Monitoring Committee for more than 20 multicenter clinical trials sponsored by NIH or industry.

 Back to Top  

Cynthia Owsley  Cynthia Owsley, PhD, MSPH, FARVO, is the Nathan E. Miles Chair, Professor, and Vice Chair for Research Administration in the Department of Ophthalmology, School of Medicine at the University of Alabama at Birmingham (UAB). Owsley has been participating in the annual ARVO meeting since 1981.

She is a Phi Beta Kappa graduate of Wheaton College, Massachusetts, and received her PhD in Experimental Psychology from Cornell University where she was a National Science Foundation Pre-doctoral Fellow. She received the MSPH in Epidemiology from UAB.
Owsley’s research program focuses on aging-related eye disease and vision impairment. Her research program uses a variety of research techniques including those from the fields of epidemiology, clinical trials, psychophysics, translational research, and health services research. She has been continuously funded by the National Institutes of Health since 1983, being a grant recipient from both the National Eye Institute and the National Institute on Aging. She also has received research funding from the Centers for Disease Control and Prevention, Research to Prevent Blindness, Prevent Blindness America, the EyeSight Foundation of Alabama, General Motors Corporation, Pfizer, and Genentech. She has over 200 publications indexed in PubMed.

Owsley has served on panels for the National Research Council including the Committee on Vision and the Committee on Disability Determination for Individuals with Vision Impairment as well as the Transportation Research Board’s Committee on the Safe Mobility of Older Persons. She is a voting member of the Food and Drug Administration’s Ophthalmic Devices Panel of the Medical Devices Advisory Committee. From 2005-2007 Owsley chaired the scientific review panel for NIH’s Center for Scientific Review on Central Visual Processing, and served as a regular member of the Visual Sciences B (VISB) Study Section for NIH in the 1990s. She serves on the editorial board of Investigative Ophthalmology and Visual Science and Current Eye Research, and completed an 8-year term on the editorial board of Vision Research.

She is an Inaugural Fellow of the Association for Research in Vision and Ophthalmology, and has Gold Fellow status. Owsley serves as the current Chair of ARVO’s Ethics and Regulations in Human Research Committee and was a member of the group that facilitated the formation of the Low Vision interest group and creation of the Oberdorfer Award. She has participated in the Women in Eye and Vision Research’s (WEAVR) luncheon at ARVO since its inception, sponsoring a table on behalf of her institution, UAB, as well as serving on the Silent Auction and Luncheon Committees in support of WEAVR. Owsley is a Fellow of the Gerontological Society of America. She serves on the Board of Directors of Prevent Blindness and Chairs its Scientific Advisory Committee. Owsley is the recipient of the Glenn A. Fry Award of the American Optometric Foundation and the Bartimaeus Award of the Detroit Institute of Ophthalmology.


 

Visual Neuroscience (VN) Section

Maureen McCall  Maureen A. McCall, PhD, is Professor, and Kentucky Lions Eye Endowed Chair in the Department of Ophthalmology and Visual Sciences, and Professor in the Department of Anatomical Sciences and Neurobiology at the University of Louisville, School of Medicine. Her scientific career has been dedicated to vision research since graduate school. She received her PhD in Neurobiology from the State University of New York at Albany where she studied visual cortex plasticity and function with Professor Helmut Hirsch. 

She pursued visual system plasticity and function with Professor Peter Spear and then retinal structure and function with Professor Lawrence Stanford at the University of Wisconsin, Madison. Throughout her career, her research has focused on understanding information processing and plasticity the normal visual system and how disease affects processing in the retina. Work from her laboratory includes both genetic and molecular manipulations of the visual system as well as therapeutic approaches to ameliorate the effects of degenerative retinal diseases. She has been an ARVO member since 1977 and regularly attends Annual ARVO meetings.

McCall has held key leadership positions in vision research and ophthalmology. She is currently the Chair of the NIH Study Section, Neurotransmitters, Receptors and Calcium Signaling. She has served on and/or chaired numerous ARVO committees including the Program Committee for VN and the Publication Committee and she has served on the most recent ARVO strategic planning committee. She has planned a variety of research meetings outside of ARVO, including the FASEB meeting for Retinal Neurobiology and Visual Processing, and two consecutive meetings of The Laboratory Mouse in Vision Research at The Jackson Laboratory, Bar Harbor, ME. She has or served on the Editorial Board of Visual Neuroscience is currently on the Editorial Board of TVST. This experience attests to Maureen’s direct experience in the operation of a wide range of organizations devoted to promoting vision research.

McCall is or has been funded from numerous sources for her work vision science since 2000, the NSF, the NIH/NEI and the Foundation Fighting Blindness. Because of her background in many structures within the visual system, she thinks broadly about visual information processing, although her current interests focus on the retina. She would bring to the role of Trustee a wealth of knowledge about programmatic as well as scientific issues. She has mentored many graduate and postdoctoral students, who have chosen both traditional and non-traditional career paths. This experience would help in issues related to professional development as a VN trustee. She is well-informed on both basic and translational science in the retina. She has worked in leadership roles with both small and large groups on issues related to the advancement of Visual Neuroscience within ARVO and, generally of ARVO itself. Her expertise make her an excellent candidate for ARVO Trustee of the Visual Neurophysiology Scientific Section. 

Commercial and/or financial interests: None.

 

Advertisement
EverSight-April 30